2m 2m 2m 2m 2m 2m 2m
Interpace Biosci (IDXG)
OTC
$1.75-$0.01 (-0.57%)
Price as of Jun 03, 2026- $4.5MMarket Cap
- 98.86%1-Year Change
- Diagnostics & ResearchIndustry
Interpace Biosci (IDXG)
$1.75-$0.01 (-0.57%)
IDXG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.75 | ||
Change | -$0.01 (-0.57%) | ||
Open | $1.75 | ||
High | $1.75 | ||
Low | $1.75 | ||
Previous Close | $1.76 | ||
Volume | 1,561 | ||
30-Day Average Volume | 7,599 | ||
1-Week Change | -2.78% | ||
1-Month Change | -17.45% | ||
1-Year Change | 98.86% | ||
3-Year Change | -28.28% | ||
5-Year Change | -55.36% | ||
Fundamentals | |||
Shares Outstanding | 4.3M | ||
Total Assets | $14.3M | ||
Market Cap | $4.5M | ||
Enterprise Value | $16.0M | ||
Period: QTR TTM FY | |||
Revenue | $9.1M | ||
Net Income | -$614,000.00 | ||
Free Cash Flow | $953,000.00 | ||
EBIT | -$610,000.00 | ||
EBITDA | -$370,000.00 | ||
Net Working Capital | -$886,000.00 | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 2 | ||
P/B | -0 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | 5 | ||
Price/Operating Cash Flow | 4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 01/15/2020 | ||